Back
Virtus Dividend, Interest & Premium Strategy Fund Vs. Viking Therapeutics Industry Stock Comparison
Buy
74
NFJ
Virtus Dividend, Interest & Premium Strategy Fund
Last Price:
12.29
Seasonality Move:
-2.46%
Buy
54
VKTX
Viking Therapeutics
Last Price:
51.26
Seasonality Move:
6.26%
Buy
74
Virtus Dividend, Interest & Premium Strategy Fund (NFJ)
is a Buy
Is Virtus Dividend, Interest & Premium Strategy Fund a Buy, Sell or Hold?
- The current Virtus Dividend, Interest & Premium Strategy Fund [NFJ] share price is $12.29. The Score for NFJ is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- NFJ is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $51.27. The Score for VKTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NFJ Stock Price Chart
What is Virtus Dividend, Interest & Premium Strategy Fund's stock price today?
-
The Virtus Dividend, Interest & Premium Strategy Fund share price today is $12.29
The current trend is moderately bullish and NFJ is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $51.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
NFJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 51.44 | Buy |
| Chaikin Money Flow: | -55223 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.16 - 12.36) | Buy |
| Bollinger Bands (100): | (12.08 - 12.46) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.92 | Sell |
| Relative Strength Index (14 RSI): | 42.17 | Sell |
| Chaikin Money Flow: | -7165 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.73 - 57.75) | Sell |
| Bollinger Bands (100): | (49.81 - 78.71) | Sell |
NFJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.28 | Buy |
| 20-day SMA: | 12.26 | Buy |
| 50-day SMA: | 12.25 | Buy |
| 200-day SMA: | 12 | Buy |
| 8-day EMA: | 12.29 | Buy |
| 20-day EMA: | 12.26 | Buy |
| 50-day EMA: | 12.26 | Buy |
| 200-day EMA: | 12.15 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.94 | Buy |
| 20-day SMA: | 52.11 | Sell |
| 50-day SMA: | 62.69 | Sell |
| 200-day SMA: | 39.93 | Buy |
| 8-day EMA: | 51.54 | Sell |
| 20-day EMA: | 53.48 | Sell |
| 50-day EMA: | 58.29 | Sell |
| 200-day EMA: | 45.95 | Buy |
Virtus Dividend, Interest & Premium Strategy Fund Earnings Growth & NFJ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Virtus Dividend, Interest & Premium Strategy Fund Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||